Addison Biological Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 4.35 M
as on 16-11-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.69 Cr
as on 16-11-2024
- Satisfied Charges ₹ 3.81 Cr
as on 16-11-2024
- Revenue -7.85%
(FY 2023)
- Profit -13.79%
(FY 2023)
- Ebitda -5.63%
(FY 2023)
- Net Worth 24.45%
(FY 2023)
- Total Assets 19.21%
(FY 2023)
About Addison Biological
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.35 M.
The company currently has active open charges totaling ₹3.69 Cr. The company has closed loans amounting to ₹3.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Bansal, Sanjay Garg, Navneet Sharma, and One other member serve as directors at the Company.
- CIN/LLPIN
U24303PB2017PTC046362
- Company No.
046362
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Barnala, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Addison Biological?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Bansal  | Director | 19-Apr-2017 | Current |
| Sanjay Garg | Whole-Time Director | 19-Apr-2017 | Current |
| Navneet Sharma | Director | 19-Apr-2017 | Current |
| Jasdeep Singh | Director | 12-Dec-2022 | Current |
Financial Performance of Addison Biological.
Addison Biological Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.85% decrease. The company also saw a substantial fall in profitability, with a 13.79% decrease in profit. The company's net worth Soared by an impressive increase of 24.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Addison Biological?
In 2022, Addison Biological had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ritz Agro Chemicals Private LimitedActive 12 years 3 months
Sanjay Garg and Navneet Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 May 2024 | ₹0.77 M | Open |
Others Creation Date: 21 Oct 2023 | ₹9.98 M | Open |
Others Creation Date: 17 Jan 2023 | ₹0.52 M | Open |
How Many Employees Work at Addison Biological?
Unlock and access historical data on people associated with Addison Biological, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Addison Biological, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Addison Biological's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
